Insider Transactions in Q4 2021 at Meridian Bioscience Inc (VIVO)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2021
|
Bryan T Baldasare Exec VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,985
-3.16%
|
$33,745
$17.92 P/Share
|
|
Dec 15
2021
|
Lourdes Weltzien Executive VP, Life Science |
SELL
Payment of exercise price or tax liability
|
Direct |
320
-0.38%
|
$5,440
$17.92 P/Share
|
|
Nov 15
2021
|
Bryan T Baldasare Exec VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,807
-5.71%
|
$76,140
$20.16 P/Share
|
|
Nov 15
2021
|
Lourdes Weltzien Executive VP, Life Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,269
-4.87%
|
$85,380
$20.16 P/Share
|
|
Nov 15
2021
|
Tony Serafini Lamanna Executive VP-Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,232
-5.26%
|
$44,640
$20.16 P/Share
|
|
Nov 15
2021
|
John P. Kenny Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
155,511
+36.97%
|
-
|
|
Nov 15
2021
|
John P. Kenny Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
155,511
-58.65%
|
-
|
|
Nov 15
2021
|
Bryan T Baldasare Exec VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
32,557
+32.79%
|
-
|
|
Nov 15
2021
|
Bryan T Baldasare Exec VP & CFO |
SELL
Other acquisition or disposition
|
Direct |
32,557
-48.8%
|
-
|
|
Nov 15
2021
|
Tony Serafini Lamanna Executive VP-Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
24,343
+36.45%
|
-
|
|
Nov 15
2021
|
Tony Serafini Lamanna Executive VP-Diagnostics |
SELL
Other acquisition or disposition
|
Direct |
24,343
-57.36%
|
-
|
|
Nov 15
2021
|
Lourdes Weltzien Executive VP, Life Science |
BUY
Grant, award, or other acquisition
|
Direct |
32,709
+27.18%
|
-
|
|
Nov 15
2021
|
Lourdes Weltzien Executive VP, Life Science |
SELL
Other acquisition or disposition
|
Direct |
32,709
-37.32%
|
-
|
|
Nov 04
2021
|
John P. Kenny Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,472
+17.56%
|
-
|
|
Nov 04
2021
|
Bryan T Baldasare Exec VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
10,593
+13.7%
|
-
|
|
Nov 04
2021
|
Tony Serafini Lamanna Executive VP-Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
10,593
+19.98%
|
-
|
|
Nov 04
2021
|
Lourdes Weltzien Executive VP, Life Science |
BUY
Grant, award, or other acquisition
|
Direct |
10,593
+10.78%
|
-
|